Creating a Cardiac Pacemaker by Gene Therapy - Biopacemaking - page 62

77. Ravens U (2006) Electrophysiological properties ofstem cells. Herz 31:123-126
78. Rosen MR (2005) 15th annual Gordon K. Moe Lecture. Biological pacemaking: in our
lifetime? Heart Rhythm 2:418-428
79. Satoh H (2003) Sinoatrial nodal cells of mammalian hearts: ionic currents and gene
expression of pacemaker ionic channels. J Smooth Muscle Res 39:175-193
80. Satoh H, Tsuchida K (1993) Comparison of a calcium antagonist, CD-349, with
nifedipine, diltiazem, and verapamil in rabbit spontaneously beating sinoatrial node cells. J
Cardiovasc Pharmacol 21:685-692
81. Shi W et al (1999) Distribution and prevalence of hyperpolarization-activated cation
channel (HCN) mRNA expression in cardiac tissues. Circ Res 85:e1-e6
82. Shukla HH et al (2005) Heart failure hospitalization is more common in pacemaker
patients with sinus node dysfunction and a prolonged paced QRS duration. Heart Rhythm
2:245-251
83. Silva J, Rudy Y (2003) Mechanism of pacemaking in I(K1)-downregulated myocytes. Circ
Res 92:261-263
84. Sweeney MO, Hellkamp AS, Lee KL, Lamas GA (2005) Association of prolonged QRS
duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction.
Circulation 111:2418-2423
85. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal
stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation
105:93-98
86. Valiunas V et al (2004) Human mesenchymal stem cells make cardiac connexins and form
functional gap junctions. J Physiol 555:617-626
87. Verheijck EE, van Ginneken AC, Wilders R, Bouman LN (1999) Contribution of L-type
Ca2+ current to electrical activity in sinoatrial nodal myocytes of rabbits. Am J Physiol
276:H1064-H1077
88. Vinogradova TM, Maltsev VA, Bogdanov KY, Lyashkov AE, Lakatta EG (2005)
Rhythmic Ca2+ oscillations drive sinoatrial nodal cell pacemaker function to make the
heart tick. Ann N Y Acad Sci 1047:138-156
89. Xue T et al (2005) Functional integration of electrically active cardiac derivatives from
genetically engineered human embryonic stem cells with quiescent recipient ventricular
cardiomyocytes: insights into the development of cell-based pacemakers. Circulation
111:11-20
90. Yu H, Chang F, Cohen IS (1993) Phosphatase inhibition by calyculin A increases i(f) in
canine Purkinje fibers and myocytes. Pflugers Arch 422:614-616
91. Zhang Z et al (2002) Functional Roles of Ca(v)1.3 (alpha(1D)) calcium channel in
sinoatrial nodes: insight gained using genetargeted null mutant mice. Circ Res 90:
981-987
92. Zhang YM, Hartzell C, Narlow M, Dudley SC Jr (2002) Stem cell-derived cardiomyocytes
demonstrate arrhythmic potential. Circulation 106:1294-1299